# Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis

> **NCT00035958** · PHASE2,PHASE3 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 75 (—)

## Conditions studied

- Dermatomyositis

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Methotrexate
- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00035958
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-08
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 75 (—)
- **Why stopped:** Incorporating the recommendations of the NIH-formed DSMB in the study procedures would make the project budget over the limit for this funding mechanism.
- **Last updated:** 2013-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035958, "Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00035958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*